drugset / Trial / NCT06881264
A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this trial is to confirm the efficacy of HR17031 in controlling glycaemia in Chinese subjects with type 2 diabetes mellitus inadequately controlled on oral antidiabetic agents
Timeline
- Start
- 2024-04-30
- Primary completion
- 2025-09-19
- Completion
- 2025-09-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HR17031 | Unknown | — | — |
| Subject | insulin glargine | Protein / enzyme biologic | — | — |
Indications
No indication recorded.